tiprankstipranks

John Maraganore Insider Profile

11 Followers
John Maraganore, CEO, Director at Alnylam Pharma, holds 230.80K shares in Alnylam Pharma (Ticker: ALNY), holds ― shares in Beam Therapeutics (Ticker: BEAM), holds ― shares in Kymera Therapeutics (Ticker: KYMR).
tipranks
John Maraganore

John Maraganore
Alnylam Pharma (ALNY)
CEO, Director

Ranked #343 out of 98,564 Corporate Insiders

Profitable Transactions

48%
10 out of 21 Profitable Transactions

Average Return

+58.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$49M
69.41%
28.62%
1.97%
0.01%
0.00% Others
A breakdown of John Maraganore's holdings

Insider Roles

Alnylam Pharma
(ALNY)
CEO, Director
Regulus
(RGLS)
Director, Ten Percent Owner
Agios Pharma
(AGIO)
Director
Bluebird Bio
(BLUE)
Director
+3 other positions
Roles that John Maraganore holds in companies

Most Profitable Insider Trade

Stock:
Bluebird Bio
(BLUE)
Rating:Informative Buy
Date:Jul 14, 2014 - Jul 14, 2015
Return:+386.00%
The most profitable trade made by John Maraganore

John Maraganore's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Alnylam Pharma
Dec 23, 2021
CEO, Director
Uninformative Buy
$33.71M
Beam Therapeutics
Director
Kymera Therapeutics
Director
ProKidney
Director
Agios Pharma
May 24, 2022
Director
Uninformative Buy
$955.19K
Bluebird Bio
Sep 18, 2017
Director
Informative Buy
39.43K
$5.13K
Regulus
Oct 11, 2012
Director, Ten Percent Owner
Uninformative Buy
$13.90M
List of latest transactions for each holding click on a transaction to see John Maraganore's performance on stock

John Maraganore insider profile FAQ

What is the percentage of profitable transactions made by John Maraganore?
The percentage of profitable transactions made by John Maraganore is 48%.
    What is the average return per transaction made by John Maraganore?
    The average return per transaction made by John Maraganore is 58.30%.
      What stocks does John Maraganore hold?
      John Maraganore holds: ALNY, BEAM, KYMR, PROK, AGIO, BLUE, RGLS stocks.
        What was John Maraganore’s latest transaction?
        John Maraganore latest transaction was an Uninformative Buy of ―.
          What was John Maraganore's most profitable transaction?
          John Maraganore’s most profitable transaction was an Informative Buy of BLUE stock on July 14, 2014. The return on the trade was 386.00%.
            What is John Maraganore's role in Alnylam Pharma?
            John Maraganore's role in Alnylam Pharma is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.